Cantabio Pharmaceuticals Inc. — Net Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/976b77a8-5d0f-4bd0-9bc8-d68fd960e981/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2017 | $-2.0M | 2017-04-01 – 2018-03-31 | evidence 0001654954-18-007670 |
| FY 2016 | $-1.1M | 2016-04-01 – 2017-03-31 | evidence 0001424884-17-000049 |
| FY 2015 | $-751.3k | 2015-04-01 – 2016-03-31 | evidence 0001424884-16-000246 |
| FY 2014 | $78.3k | 2014-04-01 – 2015-03-31 | evidence 0001424884-16-000246 |
| FY 2013 | $-120.4k | 2012-02-06 – 2014-03-31 | evidence 0001255294-14-000683 |
| FY 2012 | $-33.5k | 2012-02-06 – 2013-03-31 | evidence 0001477932-13-003031 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).